Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats
Version of Record online: 18 OCT 2013
© 2013 John Wiley & Sons Ltd
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Journal of Veterinary Pharmacology and Therapeutics
Volume 37, Issue 2, pages 161–168, April 2014
How to Cite
Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats. J. vet. Pharmacol. Therap. 37, 161–168., , , , ,
- Issue online: 6 MAR 2014
- Version of Record online: 18 OCT 2013
- Manuscript Accepted: 23 AUG 2013
- Manuscript Received: 4 FEB 2013
- 1999) Clinical approach to bleeding dog or cat. Veterinary Medicine, May, 450–459. (
- FDA Center for Veterinary Medicine (CVM) Guidance for Industry 104: Content and Format of Effectiveness and Target Animal Safety Technical Sections and Final Study Reports for Submission to the Division of Therapeutic Drugs for Non-Food Animals, July 2001.
- Guidance for industry, Bioanalytical method validation, May 2001: US Department of Health and Human Service, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM), 7500 Standish Place, Rockville, MD 20855, USA.
- 2011) Adverse events in 50 cats with allergic dermatitis receiving ciclosporin. Veterinary Dermatology, 22, 511–520. , & (
- 2012) A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis. Veterinary Dermatology, 23, 440–e84. , , , , , & (
- 1999) The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats. Veterinary Surgery, 28, 448–455. & (
- 2003) Disposition of cyclosporine after intravenous and multi-dose oral administration in cats. Journal of Veterinary Pharmacology and Therapeutics, 26, 349–354. , , , & (
- 1994) Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharmaceutical Research, 11, 301–304. , , , , & (
- 2000) Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science, 68, 15–21. , , , & (
- 2006) Prospective open pilot study on the use of ciclosporin for feline allergic skin disease. Journal of Small Animal Practice, 47, 434–438. & (
- 2013) Cyclosporine in Veterinary Dermatology. The Veterinary Clinics of North America. Small Animal Practice, 43, 153–171. (
- Public Health Service Policy on Humane Care and Use of Laboratory Animals (1986) National Institutes of Health (US) Office of Protection from Research Risks.
- 2003a) Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Veterinary Record, 152, 739–748. (
- 2003b) Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy in dogs, cats and people. Veterinary Record, 152, 768–772. (
- 1982) Experimental toxicological studies with cyclosporin A. In Cyclosporin A. Ed. White, D.J.G., pp 45–75. Elsevier Biomedical Press, Amsterdam. (
- Swiss Ordinance relating to Good Laboratory Practice, adopted May 18, 2005 [RS 813.112.1] and based on The OECD Principles of Good Laboratory Practice, as revised in 1997 and adopted on November 26, 1997 by decision of the OECD Council C (97) 186/Final.
- 2000) Dose-dependent pharmacokinetics of cyclosporine A in rats: events in tissues. Drug Metabolism Disposition, 28, 582–589. , & (
- 2001) The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transplant Infectious Disease, 3, 60–69. & (
- Target Animal Safety Guidelines for New Animal Drugs, Center for Veterinary Medicine (CVM), Food and Drug Administration, June 1989, and U.S. Food and Drug Administration (CVM Guideline 33).
- United States Department of Agriculture (2009). Title 9 Code of Federal Regulations. Animal Welfare 7 U.S.C. 2131-2159; 7 CFR 2.22, 2.80, and 371.7
- 1997) Cyclosporine and tacrolimus. Seminars in Veterinary Medicine and Surgery (Small Animal), 12, 161–166. (
- 2006) The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases. Veterinary Dermatology, 17, 201–206. , & (
- 1999) Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica, 29, 3–9. , , & (
- 2009) The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study. The Veterinary Journal, 180, 55–59. & (